JPY 1478.5
(1.86%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 33.26 Billion JPY | -3.53% |
2022 | 34.47 Billion JPY | -0.85% |
2021 | 34.77 Billion JPY | 2.61% |
2020 | 33.88 Billion JPY | -6.35% |
2019 | 36.18 Billion JPY | -35.15% |
2018 | 55.8 Billion JPY | 3.87% |
2017 | 53.72 Billion JPY | 24.99% |
2016 | 42.98 Billion JPY | -21.99% |
2015 | 55.09 Billion JPY | 25.96% |
2014 | 43.74 Billion JPY | -0.85% |
2013 | 44.12 Billion JPY | -0.28% |
2012 | 44.24 Billion JPY | 23.01% |
2011 | 35.97 Billion JPY | 3.76% |
2010 | 34.66 Billion JPY | -15.49% |
2009 | 41.01 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 36.42 Billion JPY | 9.51% |
2024 Q2 | 32.59 Billion JPY | -10.51% |
2023 Q4 | 33.26 Billion JPY | 2.77% |
2023 FY | 33.26 Billion JPY | -3.53% |
2023 Q1 | 34.69 Billion JPY | 0.63% |
2023 Q2 | 35.94 Billion JPY | 3.6% |
2023 Q3 | 32.36 Billion JPY | -9.95% |
2022 Q1 | 33.29 Billion JPY | -4.25% |
2022 Q2 | 33.03 Billion JPY | -0.79% |
2022 Q3 | 30.92 Billion JPY | -6.4% |
2022 FY | 34.47 Billion JPY | -0.85% |
2022 Q4 | 34.47 Billion JPY | 11.5% |
2021 Q2 | 32.55 Billion JPY | -2.98% |
2021 Q3 | 30.89 Billion JPY | -5.11% |
2021 Q4 | 34.77 Billion JPY | 12.56% |
2021 Q1 | 33.55 Billion JPY | -0.99% |
2021 FY | 34.77 Billion JPY | 2.61% |
2020 FY | 33.88 Billion JPY | -6.35% |
2020 Q1 | 37.26 Billion JPY | 2.97% |
2020 Q2 | 32.74 Billion JPY | -12.13% |
2020 Q3 | 30.74 Billion JPY | -6.1% |
2020 Q4 | 33.88 Billion JPY | 10.22% |
2019 Q1 | 41.98 Billion JPY | -24.77% |
2019 Q3 | 35.13 Billion JPY | -8.45% |
2019 Q4 | 36.18 Billion JPY | 3.0% |
2019 FY | 36.18 Billion JPY | -35.15% |
2019 Q2 | 38.37 Billion JPY | -8.58% |
2018 Q4 | 55.8 Billion JPY | 27.37% |
2018 Q3 | 43.81 Billion JPY | -6.74% |
2018 FY | 55.8 Billion JPY | 3.87% |
2018 Q1 | 47.81 Billion JPY | -11.0% |
2018 Q2 | 46.98 Billion JPY | -1.74% |
2017 Q1 | 43.31 Billion JPY | 0.78% |
2017 Q4 | 53.72 Billion JPY | 18.35% |
2017 Q3 | 45.39 Billion JPY | -1.96% |
2017 FY | 53.72 Billion JPY | 24.99% |
2017 Q2 | 46.3 Billion JPY | 6.89% |
2016 Q3 | 39.21 Billion JPY | -9.32% |
2016 FY | 42.98 Billion JPY | -21.99% |
2016 Q4 | 42.98 Billion JPY | 9.6% |
2016 Q2 | 43.24 Billion JPY | 3.35% |
2016 Q1 | 41.84 Billion JPY | -24.05% |
2015 Q1 | 40.15 Billion JPY | -8.2% |
2015 Q4 | 55.09 Billion JPY | 31.29% |
2015 Q3 | 41.96 Billion JPY | -8.36% |
2015 Q2 | 45.79 Billion JPY | 14.05% |
2015 FY | 55.09 Billion JPY | 25.96% |
2014 Q1 | 45.23 Billion JPY | 2.52% |
2014 FY | 43.74 Billion JPY | -0.85% |
2014 Q4 | 43.74 Billion JPY | 3.23% |
2014 Q3 | 42.37 Billion JPY | -6.26% |
2014 Q2 | 45.2 Billion JPY | -0.06% |
2013 Q2 | 44.7 Billion JPY | 14.85% |
2013 Q4 | 44.12 Billion JPY | 5.89% |
2013 FY | 44.12 Billion JPY | -0.28% |
2013 Q3 | 41.66 Billion JPY | -6.8% |
2013 Q1 | 38.92 Billion JPY | -12.03% |
2012 Q3 | 38.23 Billion JPY | -3.23% |
2012 Q4 | 44.24 Billion JPY | 15.72% |
2012 FY | 44.24 Billion JPY | 23.01% |
2012 Q1 | 34.3 Billion JPY | -4.64% |
2012 Q2 | 39.51 Billion JPY | 15.19% |
2011 Q4 | 35.97 Billion JPY | 2.0% |
2011 Q1 | 31.96 Billion JPY | -7.8% |
2011 FY | 35.97 Billion JPY | 3.76% |
2011 Q2 | 35.84 Billion JPY | 12.16% |
2011 Q3 | 35.26 Billion JPY | -1.63% |
2010 Q4 | 34.66 Billion JPY | 0.0% |
2010 FY | 34.66 Billion JPY | -15.49% |
2009 FY | 41.01 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -1912.513% |
Euglena Co., Ltd. | 37.92 Billion JPY | 12.291% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | -412.3% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | -128.118% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | -55.665% |
Kao Corporation | 757.7 Billion JPY | 95.61% |
Niitaka Co., Ltd. | 9.35 Billion JPY | -255.489% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 66.449% |
Shiseido Company, Limited | 615.1 Billion JPY | 94.593% |
Lion Corporation | 188.22 Billion JPY | 82.329% |
Mandom Corporation | 20.05 Billion JPY | -65.841% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -2406.862% |
Milbon Co., Ltd. | 7.45 Billion JPY | -345.884% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | -145.285% |
Fancl Corporation | 30.56 Billion JPY | -8.81% |
KOSÉ Corporation | 88.61 Billion JPY | 62.467% |
Cota Co., Ltd. | 3.85 Billion JPY | -763.331% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -747.609% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -956.291% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | -38.351% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -3025.769% |
Almado, Inc. | 1.94 Billion JPY | -1608.867% |
I-ne CO., LTD. | 8.57 Billion JPY | -287.748% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -581.578% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -756.453% |
AXXZIA Inc. | 2 Billion JPY | -1557.701% |
S.T. Corporation | 12.01 Billion JPY | -176.921% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 46.914% |
Earth Corporation | 60.4 Billion JPY | 44.937% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -326.521% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -1961.999% |
Ya-Man Ltd. | 3.97 Billion JPY | -736.456% |
MTG Co., Ltd. | 11.73 Billion JPY | -183.338% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -697.229% |
SHOBIDO Corporation | 8.89 Billion JPY | -273.834% |
Artnature Inc. | 23.42 Billion JPY | -41.977% |
Pigeon Corporation | 19.34 Billion JPY | -71.9% |
Unicharm Corporation | 345.37 Billion JPY | 90.37% |
Paltac Corporation | 222.34 Billion JPY | 85.041% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | -16.648% |